Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043) - Sleijfer, S; Ray-Coquard, I; Papai, Z (J Clin Oncol, 2009)
et al.